Financials
Financial year 2025
Dr. Katrien Lecluyse, Gastro-Enterologie from Maarkedal, company number BE0833992736, closed financial year 2025 with a result of € 157,912 after tax. For that financial year Dr. Katrien Lecluyse, Gastro-Enterologie recorded a gross margin of € 231,838 and equity of € 735,391. Compared with financial year 2024, the result moved from € 236,019 to € 157,912. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 29, 2026.
€ 735,391
▲ 12% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 157,912
▼ 33% vs 2024
Profit after tax over the fiscal year.
€ 270,389
▲ 1% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 78,200 paid out
50 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 23,410
▲ € 20,769 vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 20,714
▼ 1% vs 2024
Loans from banks and other lenders, long and short.
€ 7,034
▲ € 5,727 vs 2024
Supplier invoices still open on the last day of the fiscal year.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 130,364 | € 168,841 | € 347,645 | € 231,838 | ▼ 33% |
| Profit after taxes | € 89,866 | € 116,134 | € 236,019 | € 157,912 | ▼ 33% |
| Equity | € 527,525 | € 506,359 | € 655,678 | € 735,391 | ▲ 12% |
| Total debts | € 28,180 | € 30,814 | € 36,194 | € 34,166 | ▼ 6% |
| Cash | € 252,579 | € 219,909 | € 266,774 | € 270,389 | ▲ 1% |
| Retained profit | € 527,525 | € 506,359 | € 655,678 | € 735,391 | ▲ 12% |
| Dividend | € 0 | € 137,300 | € 86,700 | € 78,200 | ▼ 10% |
| Bank debt | € 20,524 | € 20,904 | € 20,887 | € 20,714 | ▼ 1% |
| Balance sheet total | € 555,706 | € 537,173 | € 691,872 | € 769,556 | ▲ 11% |
Key figures of Dr. Katrien Lecluyse, Gastro-Enterologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about Dr. Katrien Lecluyse, Gastro-Enterologie the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to Dr. Katrien Lecluyse, Gastro-Enterologie?
What happened at Dr. Katrien Lecluyse, Gastro-Enterologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 157,912 (▼ 33% vs 2024). Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Oudenaarde. KBO
- Katrien Lecluyse became a director. NBB
In short
From € 89,866 profit in 2022 to € 157,912 profit in 2025.
Paid € 264,775 in corporate taxes since 2022.
Best year ever: 2024, with € 236,019 profit.
Paid out € 302,200 in dividends to the owners in total.
Management
Behind Dr. Katrien Lecluyse, Gastro-Enterologie is Katrien Lecluyse.
Directors
According to the 2025 annual accounts
Katrien Lecluyse
Director
since 2011
Establishments
Establishment units
Physical locations of this company
Mussestraat 16
9680 Maarkedal
Minderbroedersstraat 3
9700 Oudenaarde
Active since 3 March 2011
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- Dokter LECLUYSE Katrien(oprichter) 100%
Details
- Company number
- 0833.992.736
- VAT number
- BE 0833.992.736
- Registered office
- Mussestraat 16, 9680 Maarkedal
- Names & denominations
- Dr. Katrien Lecluyse, Gastro-Enterologie
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 23 February 2011
- Peppol
- Active · Active since 9 Oct 2025